Method Article

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

DOI:

10.3791/58279

October 24th, 2018

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This protocol introduces a simple two-step method for differentiating corneal limbal epithelial stem cells from human pluripotent stem cells under xeno- and feeder cell-free culture conditions. The cell culture methods presented here enable cost-efficient, large-scale production of clinical quality cells applicable to corneal cell therapy use.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Corneal limbal epithelial stem cells (LESCs) are responsible for continuously renewing the corneal epithelium, and thus maintaining corneal homeostasis and visual clarity. Human pluripotent stem cell (hPSC)-derived LESCs provide a promising cell source for corneal cell replacement therapy. Undefined, xenogeneic culture and differentiation conditions cause variation in research results and impede the clinical translation of hPSC-derived therapeutics. This protocol provides a reproducible and efficient method for hPSC-LESC differentiation under xeno- and feeder cell-free conditions. Firstly, monolayer culture of undifferentiated hPSC on recombinant laminin-521 (LN-521) and defined hPSC medium serves as a foundation for robust production of high-quality starting material for differentiations. Secondly, a rapid and simple hPSC-LESC differentiation method yields LESC populations in only 24 days. This method includes a four-day surface ectodermal induction in suspension with small molecules, followed by adherent culture phase on LN-521/collagen IV combination matrix in defined corneal epithelial differentiation medium. Cryostoring and extended differentiation further purifies the cell population and enables banking of the cells in large quantities for cell therapy products. The resulting high-quality hPSC-LESCs provide a potential novel treatment strategy for corneal surface reconstruction to treat limbal stem cell deficiency (LSCD).

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The transparent cornea at the ocular surface allows light to enter the retina and provides the majority of the eye's refractive power. The outermost layer, the stratified corneal epithelium, is continuously regenerated by limbal epithelial stem cells (LESCs). The LESCs reside in the basal layer of the limbal niches at the corneoscleral junction1,2. LESCs lack specific and unique markers, so their identification requires a more extensive analysis of a set of putative markers. Epithelial transcription factor p63, and especially N-terminally truncated transcript of the alpha isoform of p63 (ΔNp63α),....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

University of Tampere has the approval of the National Authority for Medicolegal affairs Finland (Dnro 1426/32/300/05) to conduct research on human embryos. The institute also has supportive statements of the Ethical Committee of the Pirkanmaa Hospital District to derive, culture, and differentiate hESC lines (Skottman/R05116) and to use hiPSC lines in ophthalmic research (Skottman/R14023). No new cell lines were derived for this study.

NOTE: The protocol described is based on specific, commercially available hPSC and corneal epithelium differentiation media. Please refer to the Table of Materials for manufacturer/supplier ....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

From hPSCs to hPSC-LESCs

The entire process from inducing differentiation of FF hPSCs to cryostoring hPSC-LESCs takes around 3.5 weeks. Schematic overview of the differentiation method highlighting its key steps is presented in Figure 1A. Figure 1B shows typical morphologies of cell populations in different phases of the protocol. The data presented are obtained with Regea.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The expected result of this protocol is the successful and robust generation of LESCs from a single cell suspension of FF hPSC within approximately 3.5 weeks. As corneal epithelium develops from surface ectoderm29, the first step of the protocol aims at steering hPSCs towards this lineage. A short 24 h induction with transforming growth factor beta (TGF-β) antagonist SB-505124, and bFGF are used to induce ectodermal differentiation, followed by 48 h mesodermal BMP-4 cue to push the cells towa.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have nothing to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The study was supported by the Academy of Finland (grant number 297886), the Human spare parts program of Tekes, the Finnish Funding Agency for Technology and Innovation, the Finnish Eye and Tissue Bank Foundation and the Finnish Cultural Foundation. The authors thank the biomedical laboratory technicians Outi Melin, Hanna Pekkanen, Emma Vikstedt, and Outi Heikkilä for excellent technical assistance and contribution to cell culture. Professor Katriina Aalto-Setälä is acknowledged for providing the hiPSC line used and BioMediTech Imaging Core facility for providing equipment for fluorescence imaging.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Material/Reagent
1x DPBS containing Ca2+ and Mg2+Gibco#14040-091
1x DPBS without Ca2+ and Mg2+Lonza#17-512F/12
100 mm cell culture dishCorning CellBIND#3296Culture vessel format for adherent hPSC-LESC differentiation
12-well plateCorning CellBIND#3336Culture vessel format for IF samples
24-well plateCorning CellBIND#3337Culture vessel format for IF samples
2-mercaptoethanolGibco#31350-010
6-well plate, Ultra-Low attachmentCorning Costar#3471Culture vessel format for induction in suspension culture
Alexa Fluor 488 anti-mouse IgThermoFisher Scientific#A-21202Secondary antibody for IF
Alexa Fluor 488 anti-rabbit IgThermoFisher Scientific#A-21206Secondary antibody for IF
Alexa Fluor 568 anti-goat IgThermoFisher Scientific#A-11057Secondary antibody for IF
Alexa Fluor 568 anti-mouse IgThermoFisher Scientific#A-10037Secondary antibody for IF
Basic fibroblast growth factor (bFGF, human)PeproTech Inc.#AF-100-18BAnimal-Free Recombinant Human FGF-basic (154 a.a.)
BD Cytofix/Cytoperm Fixation/Permeabilization SolutionBD Biosciences#554722Fixation and permeabilization solution for flow cytometry
BD Perm/Wash BufferBD Biosciences#554723Washing buffer for flow cytometry
BlebbistatinSigma-Aldrich#B0560
Bone morphogenetic protein 4 (BMP-4)PeproTech Inc.#120-05A
Bovine serum albumin (BSA)Sigma-Aldrich#A8022-100G
Cytokeratin 12 antibodySanta Cruz Biotechnology#SC-17099Primary antibody for IF
Cytokeratin 14 antibodyR&D Systems#MAB3164Primary antibody for IF
Cytokeratin 15 antibodyThermoFisher Scientific#MS-1068-PPrimary antibody for IF
CnT-30CELLnTEC Advanced Cell Systems AG#Cnt-30Culture medium for adherent hPSC-LESC differentiation
Collagen type IV (human)Sigma-Aldrich#C5533Human placental collagen type IV
CoolCell LX Freezing ContainerSigma-Aldrich#BCS-405
CryoPure tubesSarsted#72.3801.6 mL cryotube for hPSC-LESC cryopreservation
Defined Trypsin InhibitorGibco#R-007-100
Essential 8 Flex Medium KitThermo Fisher Scientific#A2858501
GlutaMAXGibco#35050061
Laminin 521Biolamina#Ln521Human recombinant laminin 521
ΔNp63α antibodyBioCare Medical#4892Primary antibody for IF
OCT3/4 antibodyR&D Systems#AF1759Primary antibody for IF
p63α antibodyCell Signaling Technology#ACI3066APrimary antibody for IF
p63-α (D2K8X) XP Rabbit mAb (PE Conjugate)Cell Signaling Technology#56687p63-α PE-conjugated antibody for flow cytometry
PAX6 antibodySigma-Aldrich#HPA030775Primary antibody for IF
Penicillin/StreptomycinLonza#17-602E
Paraformaldehyde (PFA)Sigma-Aldrich#158127Cell fixative for IF
ProLong Gold Antifade Mountant with DAPIThermo Fisher Scientific#P36931DAPI mountant for hard mounting for IF
PSC Cryopreservation KitThermo Fisher Scientific#A2644601
TrypLE Select EnzymeGibco#12563-011
KnockOut Dulbecco’s modified Eagle’s mediumGibco#10829018
KnockOut SR XenoFree CTSGibco#10828028
MEM non-essential amino acidsGibco#11140050
SB-505124Sigma-Aldrich#S4696
Triton X-100Sigma-Aldrich#T8787Permeabilization agent for IF
VectaShieldVector Laboratories#H-1200DAPI mountant for liquid mounting for IF
NameCompanyCatalog NumberComments
Equipment
Cytocentrifuge, e.g. CellSpin IITharmac
Flow cytometer, e.g. BD Accuri C6BD Biosciences
Fluorescence microscope, e.g.Olympus IX 51Olympus

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Dua, H. S., Shanmuganathan, V. A., Powell-Richards, A. O., Tighe, P. J., Joseph, A. Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche. The British Journal of Ophthalmology. 89 (5), 529-532 (2005).
  2. Yazdanpanah, G., Jabbehdari, S., Djalilian, A. R.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Corneal Limbal Epithelial Stem CellsHuman Pluripotent Stem CellsDirected DifferentiationXeno Free CultureFeeder Cell FreeLaminin 521 Collagen IVEmbryoid Body FormationSurface Ectodermal InductionAdherent DifferentiationCryopreservation

Related Articles